Channels

Wed, Oct 16 8:13pm

0 Health Care Sector

The Healthcare Sector consists of companies that offer medical services, manufacture medical equipment, drugs and medical insurance.

The industries within the Health Care Sector are Biotech & Pharma, Health Care Facilities & Services and Medical Equipment & Devices.

Noteworthy events last week, this week and next week.

Sun, Oct 13 - Sat, Oct 19

The pessimist sees difficulty in every opportunity. The optimist sees opportunity in every difficulty.
Winston Churchill

All Time Highs 52 Week Highs 52 Week Lows Earnings Annoucements
817237


Health Care Sector

JNJ $135.17 2.33 (1.75%)
Johnson & Johnson JNJNews
NYSE: JNJ $344 Billion Large-Cap. Dow Industrial. S&P 500. Biotech & Pharma industry. 5 Year Return 37%. 1 Year Return 3%. 2019 YTD Return 6%. 2.8% dividend yield. 191 total dividend payments. Dividend Aristocrat25+ consecutive years of increasing dividends. Since Earnings 3%.

JNJ Profile

Market Cap 344 Billion
JNJ Description

Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, close to half of total revenue is generated in the United States.


Visit Website

JNJ Earnings

EPS 2.11 P/E Ratio 24.34
Previous Tue, Jul 16, 2019
Latest Tue, Oct 15, 2019 (1 days ago) Price +3.40%

JNJ Dividend

Yield 2.81% / $3.80
Ex-Date Mon, Aug 26, 2019 (51 days ago)
Pay Date Tue, Sep 10, 2019
History 191 Payments (Quarterly)

JNJ Charts

$121.00
1 Year
$148.99
Dec 24, 2018
Dec 4, 2018


UNH $236.99 1.60 (0.67%)
UnitedHealth Group UHC
NYSE: UNH $222 Billion Large-Cap. Dow Industrial. S&P 500. Health Care Facilities & Services industry. 5 Year Return 169%. 1 Year Return 11%. 2019 YTD Return 3%. 1.5% dividend yield. 57 total dividend payments. Since Earnings 7%. Compare AET vs ANTM vs UNH.

UNH Profile

Market Cap 222 Billion
UNH Description

UnitedHealth Group is the largest private health insurance provider in the United States, offering medical benefits to nearly 50 million members across its U.S. and international businesses. As the leader in employer-sponsored, self-directed, and government-backed insurance plans, United has obtained unrivaled scale compared with its peers in managed care. Along with its insurance assets, United's continued investment behind its Optum franchises has created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.


Visit Website

UNH Earnings

EPS 3.47 P/E Ratio 17.22
Previous Thu, Jul 18, 2019
Latest Tue, Oct 15, 2019 (1 days ago) Price +7.43%

UNH Dividend

Yield 1.52% / $3.60
Ex-Date Fri, Mar 8, 2019 (222 days ago)
Pay Date Tue, Mar 19, 2019
History 57 Payments (Quarterly)

UNH Charts

$208.07
1 Year
$287.94
Apr 17, 2019
Dec 4, 2018


MRK $84.45 0.59 (0.69%)
Merck Merck
NYSE: MRK $212 Billion Large-Cap. Dow Industrial. S&P 500. Biotech & Pharma industry. 5 Year Return 56%. 1 Year Return 18%. 2019 YTD Return 12%. 2.6% dividend yield. 136 total dividend payments. Dogs Of The Dow. Earnings in 12 days on Tue, Oct 29. (Use the Earnings tab below to add this date to your calendar.)

MRK Profile

Market Cap 212 Billion
MRK Description

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the company's sales are generated in the United States.


Visit Website

MRK Earnings

EPS 1.04 P/E Ratio 33.85
Previous Tue, Jul 30, 2019
Latest Tue, Oct 29, 2019 (In 13 days)

MRK Dividend

Yield 2.61% / $2.20
Ex-Date Fri, Sep 13, 2019 (33 days ago)
Pay Date Mon, Oct 7, 2019
History 136 Payments (Quarterly)

MRK Charts

$66.10
1 Year
$87.35
Oct 25, 2018
Aug 29, 2019


PFE $36.34 0.16 (0.44%)
Pfizer pfizer
NYSE: PFE $207 Billion Large-Cap. Dow Industrial. S&P 500. Biotech & Pharma industry. 5 Year Return 31%. 1 Year Return 18%. 2019 YTD Return 16%. 4.0% dividend yield. 136 total dividend payments. Current Ex-Date in 21 days on Thu, Nov 7. (Use the Dividend tab below to add this date to your calendar.) Thu, Nov 7. Dogs Of The Dow. Earnings in 12 days on Tue, Oct 29. (Use the Earnings tab below to add this date to your calendar.)

PFE Profile

Market Cap 207 Billion
PFE Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total company sales.


Visit Website

PFE Earnings

EPS 0.91 P/E Ratio 11.28
Previous Mon, Jul 29, 2019
Latest Tue, Oct 29, 2019 (In 13 days)

PFE Dividend

Yield 3.96% / $1.44
Ex-Date Thu, Nov 7, 2019 (In 22 days)
Pay Date Mon, Dec 2, 2019
History 136 Payments (Quarterly)

PFE Charts

52 Week Low $33.97 set on Thu, Aug 15, 2019
$33.97
1 Year
$46.47
Aug 15, 2019
Dec 4, 2018


NVS $87.00 0.30 (0.35%)
Novartis AG Novartis
NYSE: NVS $203 Billion Large-Cap. Drug Manufacturers industry. 5 Year Return 14%. 1 Year Return 16%. 2019 YTD Return 18%. 3.3% dividend yield. 28 total dividend payments. Paid Annually. Earnings in 5 days on Tue, Oct 22. (Use the Earnings tab below to add this date to your calendar.)

NVS Profile

Market Cap 203 Billion
NVS Description

Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total sales.


Visit Website

NVS Earnings

EPS 2.94 P/E Ratio 15.59
Previous Thu, Jul 18, 2019
Latest Tue, Oct 22, 2019 (In 6 days)

NVS Dividend

Yield 3.26% / $2.83
Ex-Date Mon, Mar 4, 2019 (226 days ago)
Pay Date Wed, Mar 13, 2019
History 28 Payments (Annually)

NVS Charts

All Time High $95.00 set on Thu, Jul 18, 2019.
$72.05
1 Year
$95.00
Dec 27, 2018
Jul 18, 2019


ABT $81.78 0.20 (0.24%)
Abbott Laboratories AbbottNews
NYSE: ABT $149 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 100%. 1 Year Return 16%. 2019 YTD Return 18%. 1.6% dividend yield. 136 total dividend payments. Dividend Aristocrat25+ consecutive years of increasing dividends. Earnings Today. Compare ABBV vs ABT.

ABT Profile

Market Cap 149 Billion
ABT Description

Abbott manufactures and markets medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and molecular and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.


Visit Website

ABT Earnings

EPS 0.57 P/E Ratio 59.16
Previous Wed, Jul 17, 2019
Latest Wed, Oct 16, 2019 Today

ABT Dividend

Yield 1.57% / $1.28
Ex-Date Fri, Oct 11, 2019 (5 days ago)
Pay Date Fri, Nov 15, 2019
History 136 Payments (Quarterly)

ABT Charts

All Time High $88.76 set on Tue, Jul 23, 2019.
$65.44
1 Year
$88.76
Dec 24, 2018
Jul 23, 2019


MDT $108.50 0.31 (0.29%)
Medtronic Medtronic
NYSE: MDT $146 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 75%. 1 Year Return 12%. 2019 YTD Return 23%. 2.0% dividend yield. 138 total dividend payments. Dividend Aristocrat25+ consecutive years of increasing dividends.

MDT Profile

Market Cap 146 Billion
MDT Description

Medtronic PLC is one of the largest medical device companies, develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for about 45% of the company's total sales.


Visit Website

MDT Earnings

EPS 0.64 P/E Ratio 24.06
Previous Tue, Aug 20, 2019
Latest Tue, Nov 19, 2019 (In 34 days)

MDT Dividend

Yield 1.99% / $2.16
Ex-Date Thu, Sep 26, 2019 (20 days ago)
Pay Date Fri, Oct 18, 2019
History 138 Payments (Quarterly)

MDT Charts

All Time High $112.05 set on Tue, Sep 24, 2019.
$81.66
1 Year
$112.05
Jan 8, 2019
Sep 24, 2019


TMO $280.56 5.46 (1.91%)
Thermo Fisher Scientific thermofisher
NYSE: TMO $118 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 150%. 1 Year Return 20%. 2019 YTD Return 28%. 0.3% dividend yield. 32 total dividend payments. Earnings in 6 days on Wed, Oct 23. (Use the Earnings tab below to add this date to your calendar.)

TMO Profile

Market Cap 118 Billion
TMO Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments: analytical technologies (23% of sales); specialty diagnostic products (15%); life science solutions (26%); and lab products and services (41%).


Visit Website

TMO Earnings

EPS 2.80 P/E Ratio 35.21
Previous Wed, Jul 24, 2019
Latest Wed, Oct 23, 2019 (In 7 days)

TMO Dividend

Yield 0.27% / $0.76
Ex-Date Mon, Sep 16, 2019 (30 days ago)
Pay Date Tue, Oct 15, 2019
History 32 Payments (Quarterly)

TMO Charts

All Time High $305.45 set on Wed, Jul 3, 2019.
$208.34
1 Year
$305.45
Dec 26, 2018
Jul 3, 2019


NVO $52.29 0.18 (0.34%)
Novo Nordisk A/S novonordisk
NYSE: NVO $118 Billion Large-Cap. Biotech & Pharma industry. 5 Year Return 18%. 1 Year Return 20%. 2019 YTD Return 12%. 3.0% dividend yield. 38 total dividend payments. Paid Biannually. Earnings in 21 days on Thu, Nov 7. (Use the Earnings tab below to add this date to your calendar.)

NVO Profile

Market Cap 118 Billion
NVO Description

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.


Visit Website

NVO Earnings

EPS 4.03 P/E Ratio 18.42
Previous Fri, Aug 9, 2019
Latest Thu, Nov 7, 2019 (In 22 days)

NVO Dividend

Yield 3.02% / $1.58
Ex-Date Fri, Mar 22, 2019 (208 days ago)
Pay Date Tue, Apr 2, 2019
History 38 Payments (Biannual)

NVO Charts

$41.59
1 Year
$53.55
Oct 25, 2018
Sep 4, 2019


AMGN $203.21 1.45 (0.71%)
Amgen Amgen
NASDAQ: AMGN $117 Billion Large-Cap. Nasdaq 100. S&P 500. Biotech & Pharma industry. 5 Year Return 52%. 1 Year Return 0%. 2019 YTD Return 6%. 2.9% dividend yield. 33 total dividend payments. Earnings in 12 days on Tue, Oct 29. (Use the Earnings tab below to add this date to your calendar.)

AMGN Profile

Market Cap 117 Billion
AMGN Description

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).


Visit Website

AMGN Earnings

EPS 3.59 P/E Ratio 15.15
Previous Tue, Jul 30, 2019
Latest Tue, Oct 29, 2019 (In 13 days)

AMGN Dividend

Yield 2.85% / $5.80
Ex-Date Wed, Aug 14, 2019 (63 days ago)
Pay Date Fri, Sep 6, 2019
History 33 Payments (Quarterly)

AMGN Charts

All Time High $211.90 set on Tue, Aug 13, 2019.
$166.30
1 Year
$211.90
May 15, 2019
Aug 13, 2019


AZN $43.79 0.42 (0.95%)
Astrazeneca AstraZeneca
NYSE: AZN $113 Billion Large-Cap. Drug Manufacturers industry. 5 Year Return 29%. 1 Year Return 11%. 2019 YTD Return 16%. 2.0% dividend yield. 51 total dividend payments. Paid Biannually. Earnings in 7 days on Thu, Oct 24. (Use the Earnings tab below to add this date to your calendar.)

AZN Profile

Market Cap 113 Billion
AZN Description

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology, and neuroscience. The majority of sales come from international markets with the United States representing close to one third of its sales.


Visit Website

AZN Earnings

EPS 0.05 P/E Ratio 46.84
Previous Thu, Jul 25, 2019
Latest Thu, Oct 24, 2019 (In 8 days)

AZN Dividend

Yield 2.04% / $0.90
Ex-Date Thu, Aug 9, 2018 (433 days ago)
Pay Date Mon, Sep 10, 2018
History 51 Payments (Biannual)

AZN Charts

All Time High $46.22 set on Thu, Sep 26, 2019.
$35.30
1 Year
$46.22
Jan 28, 2019
Sep 26, 2019


SNY $44.92 0.51 (1.15%)
Sanofi SA (ADR) sanofi
NYSE: SNY $109 Billion Large-Cap. Biotech & Pharma industry. 5 Year Return 13%. 1 Year Return 1%. 2019 YTD Return 5%. 3.9% dividend yield. 19 total dividend payments. Paid Annually. Earnings in 14 days on Thu, Oct 31. (Use the Earnings tab below to add this date to your calendar.)

SNY Profile

Market Cap 109 Billion
SNY Description

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just under 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of sales.


Visit Website

SNY Earnings

EPS -0.04 P/E Ratio 21.78
Previous Mon, Jul 29, 2019
Latest Thu, Oct 31, 2019 (In 15 days)

SNY Dividend

Yield 3.87% / $1.74
Ex-Date Tue, May 7, 2019 (162 days ago)
Pay Date Fri, May 31, 2019
History 19 Payments (Annually)

SNY Charts

$40.00
1 Year
$45.62
Aug 5, 2019
Nov 9, 2018


LLY $107.95 1.75 (1.60%)
Eli Lilly LillyPad
NYSE: LLY $108 Billion Large-Cap. S&P 500. Biotech & Pharma industry. 5 Year Return 73%. 1 Year Return 5%. 2019 YTD Return 6%. 2.4% dividend yield. 135 total dividend payments. Earnings in 6 days on Wed, Oct 23. (Use the Earnings tab below to add this date to your calendar.)

LLY Profile

Market Cap 108 Billion
LLY Description

Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.


Visit Website

LLY Earnings

EPS 1.44 P/E Ratio 40.60
Previous Tue, Jul 30, 2019
Latest Wed, Oct 23, 2019 (In 7 days)

LLY Dividend

Yield 2.39% / $2.58
Ex-Date Wed, Aug 14, 2019 (63 days ago)
Pay Date Tue, Sep 10, 2019
History 135 Payments (Quarterly)

LLY Charts

52 Week Low $104.17 set on Thu, Oct 25, 2018
$104.17
1 Year
$132.13
Oct 25, 2018
Mar 26, 2019


ABBV $74.75 0.25 (0.34%)
AbbVie abbvie
NYSE: ABBV $103 Billion Large-Cap. S&P 500. Biotech & Pharma industry. 5 Year Return 40%. 1 Year Return 19%. 2019 YTD Return 16%. 5.7% dividend yield. 28 total dividend payments. Dividend Aristocrat25+ consecutive years of increasing dividends. Earnings in 15 days on Fri, Nov 1. (Use the Earnings tab below to add this date to your calendar.) Compare ABBV vs ABT.

ABBV Profile

Market Cap 103 Billion
ABBV Description

AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.


Visit Website

ABBV Earnings

EPS 0.49 P/E Ratio 22.14
Previous Fri, Jul 26, 2019
Latest Fri, Nov 1, 2019 (In 16 days)

ABBV Dividend

Yield 5.73% / $4.28
Ex-Date Fri, Oct 11, 2019 (5 days ago)
Pay Date Fri, Nov 15, 2019
History 28 Payments (Quarterly)

ABBV Charts

$62.66
1 Year
$94.98
Aug 15, 2019
Dec 4, 2018


GSK $42.28 0.01 (0.02%)
GlaxoSmithKline
NYSE: GSK $102 Billion Large-Cap. Drug Manufacturers industry. 5 Year Return 3%. 1 Year Return 6%. 2019 YTD Return 12%. 4.4% dividend yield. 110 total dividend payments. Earnings in 13 days on Wed, Oct 30. (Use the Earnings tab below to add this date to your calendar.)

GSK Profile

Market Cap 102 Billion
GSK Description

In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.


Visit Website

GSK Earnings

EPS 0.39 P/E Ratio 40.40
Previous Wed, Jul 24, 2019
Latest Wed, Oct 30, 2019 (In 14 days)

GSK Dividend

Yield 4.41% / $1.86
Ex-Date Thu, Aug 8, 2019 (69 days ago)
Pay Date Thu, Oct 10, 2019
History 110 Payments (Quarterly)

GSK Charts

$36.41
1 Year
$43.22
Dec 6, 2018
Sep 30, 2019


DHR $137.39 0.20 (0.15%)
Danaher
NYSE: DHR $100 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 142%. 1 Year Return 31%. 2019 YTD Return 37%. 0.5% dividend yield. 107 total dividend payments. Earnings Tomorrow.

DHR Profile

Market Cap 100 Billion
DHR Description

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences (33% of 2018 sales), diagnostics (31%), environmental and applied solutions (22%), and dental (14%). In 2019, Danaher plans to separate its dental business from the organization through an initial public offering, and Danaher also plans to acquire GE's Biopharma business, which will add to its life sciences segment.


Visit Website

DHR Earnings

EPS 0.99 P/E Ratio 26.35
Previous Thu, Jul 18, 2019
Latest Thu, Oct 17, 2019 Tomorrow

DHR Dividend

Yield 0.49% / $0.68
Ex-Date Thu, Sep 26, 2019 (20 days ago)
Pay Date Fri, Oct 25, 2019
History 107 Payments (Quarterly)

DHR Charts

All Time High $147.33 set on Fri, Sep 20, 2019.
$94.59
1 Year
$147.33
Dec 24, 2018
Sep 20, 2019


GILD $65.35 0.05 (0.08%)
Gilead Sciences GileadSciences
NASDAQ: GILD $85 Billion Large-Cap. Nasdaq 100. S&P 500. Biotech & Pharma industry. 5 Year Return 35%. 1 Year Return 14%. 2019 YTD Return 3%. 3.5% dividend yield. 15 total dividend payments. Earnings in 7 days on Thu, Oct 24. (Use the Earnings tab below to add this date to your calendar.)

GILD Profile

Market Cap 85 Billion
GILD Description

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.


Visit Website

GILD Earnings

EPS 1.48 P/E Ratio 55.20
Previous Tue, Jul 30, 2019
Latest Thu, Oct 24, 2019 (In 8 days)

GILD Dividend

Yield 3.49% / $2.28
Ex-Date Thu, Dec 13, 2018 (307 days ago)
Pay Date Fri, Dec 28, 2018
History 15 Payments (Quarterly)

GILD Charts

52 Week Low $60.32 set on Wed, Dec 26, 2018
$60.32
1 Year
$76.44
Dec 26, 2018
Oct 16, 2018


SYK $215.75 0.80 (0.37%)
Stryker
NYSE: SYK $82 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 169%. 1 Year Return 22%. 2019 YTD Return 40%. 1.0% dividend yield. 59 total dividend payments. Earnings in 12 days on Tue, Oct 29. (Use the Earnings tab below to add this date to your calendar.)

SYK Profile

Market Cap 82 Billion
SYK Description

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Approximately 35% of Stryker's total revenue currently comes from outside the United States.


Visit Website

SYK Earnings

EPS 1.29 P/E Ratio 53.35
Previous Thu, Jul 25, 2019
Latest Tue, Oct 29, 2019 (In 13 days)

SYK Dividend

Yield 0.96% / $2.08
Ex-Date Fri, Sep 27, 2019 (19 days ago)
Pay Date Thu, Oct 31, 2019
History 59 Payments (Quarterly)

SYK Charts

All Time High $223.45 set on Fri, Aug 30, 2019.
$144.75
1 Year
$223.45
Dec 26, 2018
Aug 30, 2019


BMY $51.51 0.32 (0.62%)
Bristol-Myers Squibb
NYSE: BMY $81 Billion Large-Cap. S&P 500. Biotech & Pharma industry. 5 Year Return 2%. 1 Year Return 13%. 2019 YTD Return 1%. 3.2% dividend yield. 136 total dividend payments. Earnings in 14 days on Thu, Oct 31. (Use the Earnings tab below to add this date to your calendar.) "Possible" Golden Cross (bullish) chart pattern.

BMY Profile

Market Cap 81 Billion
BMY Description

Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs.


Visit Website

BMY Earnings

EPS 0.88 P/E Ratio 15.35
Previous Thu, Jul 25, 2019
Latest Thu, Oct 31, 2019 (In 15 days)

BMY Dividend

Yield 3.18% / $1.64
Ex-Date Thu, Oct 3, 2019 (13 days ago)
Pay Date Fri, Nov 1, 2019
History 136 Payments (Quarterly)

BMY Charts

$42.48
1 Year
$59.28
Jul 23, 2019
Oct 17, 2018


BDX $252.94 0.34 (0.13%)
Becton Dickinson
NYSE: BDX $70 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 108%. 1 Year Return 3%. 2019 YTD Return 15%. 1.2% dividend yield. 136 total dividend payments. Dividend Aristocrat25+ consecutive years of increasing dividends. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

BDX Profile

Market Cap 70 Billion
BDX Description

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. International revenue accounts for 45% of the company's business. With CareFusion, BD has entered into medical systems (such as infusion pumps and ventilators) as well as procedural solutions businesses. The Bard deal gives the company a presence in urology, vascular, and oncology.


Visit Website

BDX Earnings

EPS 1.53 P/E Ratio 72.20
Previous Tue, Aug 6, 2019
Latest Tue, Nov 5, 2019 (In 20 days)

BDX Dividend

Yield 1.22% / $3.08
Ex-Date Fri, Sep 6, 2019 (40 days ago)
Pay Date Mon, Sep 30, 2019
History 136 Payments (Quarterly)

BDX Charts

All Time High $265.87 set on Mon, Oct 1, 2018.
$208.62
1 Year
$264.74
Dec 26, 2018
Sep 6, 2019


CELG $100.97 0.02 (0.02%)
Celgene
NASDAQ: CELG $70 Billion Large-Cap. New 52 WEEK HIGH today. Nasdaq 100. S&P 500. Biotech & Pharma industry. 5 Year Return 15%. 1 Year Return 20%. 2019 YTD Return 52%. Earnings in 7 days on Thu, Oct 24. (Use the Earnings tab below to add this date to your calendar.)

CELG Profile

Market Cap 70 Billion
CELG Description

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.


Visit Website

CELG Earnings

EPS 2.22 P/E Ratio 17.70
Previous Tue, Jul 30, 2019
Latest Thu, Oct 24, 2019 (In 8 days)

CELG Dividend

Yield --
Ex-Date --
Pay Date --
History --

CELG Charts

$58.59
1 Year
$101.22
Dec 26, 2018
Today


ANTM $245.02 3.92 (1.57%)
Anthem
NYSE: ANTM $64 Billion Large-Cap. S&P 500. Health Care Facilities & Services industry. 5 Year Return 113%. 1 Year Return 12%. 2019 YTD Return 4%. 1.3% dividend yield. 35 total dividend payments. Earnings in 6 days on Wed, Oct 23. (Use the Earnings tab below to add this date to your calendar.) Compare AET vs ANTM vs UNH.

ANTM Profile

Market Cap 64 Billion
ANTM Description

Anthem is one of the largest private health insurance organizations nationwide, providing medical benefits to over 40 million members. The company offers employer-sponsored, individual, and government-backed coverage plans. Anthem differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states.


Visit Website

ANTM Earnings

EPS 4.44 P/E Ratio 18.53
Previous Wed, Jul 24, 2019
Latest Wed, Oct 23, 2019 (In 7 days)

ANTM Dividend

Yield 1.31% / $3.20
Ex-Date Mon, Sep 9, 2019 (37 days ago)
Pay Date Wed, Sep 25, 2019
History 35 Payments (Quarterly)

ANTM Charts

52 Week Low $227.16 set on Wed, Apr 17, 2019
$227.16
1 Year
$317.99
Apr 17, 2019
Feb 25, 2019


CI $161.47 1.31 (0.82%)
Cigna
NYSE: CI $61 Billion Large-Cap. S&P 500. Health Care Facilities & Services industry. 5 Year Return 81%. 1 Year Return 24%. 2019 YTD Return 14%. 0.0% dividend yield. 101 total dividend payments. Paid Annually. Earnings in 14 days on Thu, Oct 31. (Use the Earnings tab below to add this date to your calendar.)

CI Profile

Market Cap 61 Billion
CI Description

Long a leader in the self-funded employer health insurance market, Cigna has expanded its reach both organically and through the recent merger with Express Scripts. The firm now operates more on par with its peers, having both a medical and pharmaceutical benefits capability that should help level the playing field in the years to come. In addition, the firm is a leader in accident, disability, and life insurance globally, although these businesses have become much less important to the overall enterprise after the Express Scripts merger to bulk up its healthcare offering.


Visit Website

CI Earnings

EPS 3.73 P/E Ratio 18.86
Previous Thu, Aug 1, 2019
Latest Thu, Oct 31, 2019 (In 15 days)

CI Dividend

Yield 0.02% / $0.04
Ex-Date Fri, Mar 8, 2019 (222 days ago)
Pay Date Wed, Apr 10, 2019
History 101 Payments (Annually)

CI Charts

$141.95
1 Year
$226.61
Apr 17, 2019
Dec 3, 2018


ISRG $530.24 2.03 (0.38%)
Intuitive Surgical
NASDAQ: ISRG $60 Billion Large-Cap. Nasdaq 100. S&P 500. Medical Equipment & Devices industry. 5 Year Return 238%. 1 Year Return 2%. 2019 YTD Return 14%. Earnings Tomorrow.

ISRG Profile

Market Cap 60 Billion
ISRG Description

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 5,000 da Vinci systems in hospitals worldwide, with 3,200 installations in the United States and a growing number in emerging markets.


Visit Website

ISRG Earnings

EPS 2.76 P/E Ratio 51.10
Previous Thu, Jul 18, 2019
Latest Thu, Oct 17, 2019 Tomorrow

ISRG Dividend

Yield --
Ex-Date --
Pay Date --
History --

ISRG Charts

$430.24
1 Year
$589.32
Dec 24, 2018
Apr 12, 2019


BSX $38.18 0.28 (0.73%)
Boston Scientific
NYSE: BSX $59 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 236%. 1 Year Return 0%. 2019 YTD Return 11%. Earnings in 6 days on Wed, Oct 23. (Use the Earnings tab below to add this date to your calendar.)

BSX Profile

Market Cap 59 Billion
BSX Description

Boston Scientific Corp produces less-invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract tests, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.


Visit Website

BSX Earnings

EPS 0.11 P/E Ratio 32.07
Previous Wed, Jul 24, 2019
Latest Wed, Oct 23, 2019 (In 7 days)

BSX Dividend

Yield --
Ex-Date --
Pay Date --
History --

BSX Charts

$31.56
1 Year
$43.84
Dec 24, 2018
Sep 6, 2019


ZTS $127.93 0.78 (0.61%)
Zoetis
NYSE: ZTS $58 Billion Large-Cap. S&P 500. Biotech & Pharma industry. 5 Year Return 262%. 1 Year Return 38%. 2019 YTD Return 51%. 0.5% dividend yield. 27 total dividend payments. Current Ex-Date in 4 days on Mon, Oct 21. (Use the Dividend tab below to add this date to your calendar.) Mon, Oct 21. Earnings in 21 days on Thu, Nov 7. (Use the Earnings tab below to add this date to your calendar.)

ZTS Profile

Market Cap 58 Billion
ZTS Description

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns more than 55% of total revenue from production animals (cattle, pigs, poultry, and so on), and companion animal (dogs, horses, cats) products make up the remainder. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.


Visit Website

ZTS Earnings

EPS 0.77 P/E Ratio 34.56
Previous Tue, Aug 6, 2019
Latest Thu, Nov 7, 2019 (In 22 days)

ZTS Dividend

Yield 0.51% / $0.66
Ex-Date Mon, Oct 21, 2019 (In 5 days)
Pay Date Mon, Dec 2, 2019
History 27 Payments (Quarterly)

ZTS Charts

All Time High $130.20 set on Tue, Oct 15, 2019.
$78.90
1 Year
$130.20
Dec 24, 2018
Oct 15, 2019


AGN $170.92 0.76 (0.45%)
Allergan PLC
NYSE: AGN $54 Billion Large-Cap. S&P 500. Biotech & Pharma industry. 5 Year Return 4%. 1 Year Return 11%. 2019 YTD Return 26%. 1.7% dividend yield. 11 total dividend payments. Earnings in 12 days on Tue, Oct 29. (Use the Earnings tab below to add this date to your calendar.)

AGN Profile

Market Cap 54 Billion
AGN Description

Allergan is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. In 2016, Allergan sold its generics and distribution segments to Teva.


Visit Website

AGN Earnings

EPS -5.37 P/E Ratio 0.00
Previous Tue, Aug 6, 2019
Latest Tue, Oct 29, 2019 (In 13 days)

AGN Dividend

Yield 1.73% / $2.96
Ex-Date Mon, Aug 12, 2019 (65 days ago)
Pay Date Fri, Sep 13, 2019
History 11 Payments (Quarterly)

AGN Charts

$114.27
1 Year
$192.69
Jun 17, 2019
Oct 17, 2018


EW $226.34 2.29 (1.00%)
Edwards Lifesciences
NYSE: EW $45 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 357%. 1 Year Return 52%. 2019 YTD Return 52%. This is Uptrending. A good sign. Earnings in 6 days on Wed, Oct 23. (Use the Earnings tab below to add this date to your calendar.)

EW Profile

Market Cap 45 Billion
EW Description

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters and retractors, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.


Visit Website

EW Earnings

EPS 1.16 P/E Ratio 49.23
Previous Tue, Jul 23, 2019
Latest Wed, Oct 23, 2019 (In 7 days)

EW Dividend

Yield --
Ex-Date --
Pay Date --
History --

EW Charts

All Time High $230.19 set on Fri, Oct 11, 2019.
$136.44
1 Year
$230.19
Oct 29, 2018
Oct 11, 2019


BAX $87.02 0.72 (0.82%)
Baxter International
NYSE: BAX $45 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 138%. 1 Year Return 20%. 2019 YTD Return 33%. 1.0% dividend yield. 115 total dividend payments. Earnings in 7 days on Thu, Oct 24. (Use the Earnings tab below to add this date to your calendar.)

BAX Profile

Market Cap 45 Billion
BAX Description

Baxter manufactures medical products across seven major reported business segments. The renal segment (33% of 2018 sales) includes peritoneal dialysis and hemodialysis products for chronically ill patients while its acute therapies segment (5%) offers kidney or other organ support tools in intensive care situations. The medication delivery segment (24% of sales) sells IV pumps, administrative sets, and solutions while its nutrition segment (8% of sales) offers parenteral nutrition therapies. The pharmaceuticals segments (19% of sales) offers injectable drugs, anesthetic gases, and compounding services. The advanced surgery segment (7% of sales) provides hemostastic products and biosurgical sealants. Contract manufacturing rounds out the remaining 5% of sales.


Visit Website

BAX Earnings

EPS 0.67 P/E Ratio 26.63
Previous Thu, Jul 25, 2019
Latest Thu, Oct 24, 2019 (In 8 days)

BAX Dividend

Yield 1.01% / $0.88
Ex-Date Thu, Aug 29, 2019 (48 days ago)
Pay Date Tue, Oct 1, 2019
History 115 Payments (Quarterly)

BAX Charts

All Time High $89.93 set on Fri, Sep 6, 2019.
$61.05
1 Year
$89.93
Oct 31, 2018
Sep 6, 2019


HCA $121.43 0.08 (0.07%)
HCA Holdings
NYSE: HCA $45 Billion Large-Cap. S&P 500. Health Care Facilities & Services industry. 5 Year Return 75%. 1 Year Return 11%. 2019 YTD Return 0%. 1.3% dividend yield. 10 total dividend payments. Earnings in 12 days on Tue, Oct 29. (Use the Earnings tab below to add this date to your calendar.)

HCA Profile

Market Cap 45 Billion
HCA Description

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. The firm owns and operates 179 hospitals and 120 outpatient surgery centers with more than 1,800 alternate site locations including physician offices, urgent care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.


Visit Website

HCA Earnings

EPS 2.29 P/E Ratio 10.81
Previous Tue, Jul 30, 2019
Latest Tue, Oct 29, 2019 (In 13 days)

HCA Dividend

Yield 1.32% / $1.60
Ex-Date Fri, Aug 30, 2019 (47 days ago)
Pay Date Mon, Sep 30, 2019
History 10 Payments (Quarterly)

HCA Charts

52 Week Low $110.31 set on Wed, Apr 17, 2019
$110.31
1 Year
$147.42
Apr 17, 2019
Dec 4, 2018


VRTX $176.09 0.05 (0.03%)
Vertex Pharmaceuticals
NASDAQ: VRTX $45 Billion Large-Cap. Nasdaq 100. S&P 500. Biotech & Pharma industry. 5 Year Return 72%. 1 Year Return 5%. 2019 YTD Return 7%. Earnings in 6 days on Wed, Oct 23. (Use the Earnings tab below to add this date to your calendar.)

VRTX Profile

Market Cap 45 Billion
VRTX Description

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, and Symdeko for cystic fibrosis, in addition to several pipeline candidates targeting this market. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.


Visit Website

VRTX Earnings

EPS 1.04 P/E Ratio 20.79
Previous Wed, Jul 31, 2019
Latest Wed, Oct 23, 2019 (In 7 days)

VRTX Dividend

Yield --
Ex-Date --
Pay Date --
History --

VRTX Charts

$151.80
1 Year
$195.81
Dec 24, 2018
Jan 22, 2019


BIIB $227.72 1.66 (0.73%)
Biogen
NASDAQ: BIIB $44 Billion Large-Cap. Nasdaq 100. S&P 500. Biotech & Pharma industry. 5 Year Return 19%. 1 Year Return 33%. 2019 YTD Return 25%. Negative 5 year, 1 year & YTD returns. You may want to avoid this one until things turn around. Check out some Uptrending symbols instead. Earnings in 5 days on Tue, Oct 22. (Use the Earnings tab below to add this date to your calendar.)

BIIB Profile

Market Cap 44 Billion
BIIB Description

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Tysabri and Tecfidera. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.


Visit Website

BIIB Earnings

EPS 7.85 P/E Ratio 10.77
Previous Tue, Jul 23, 2019
Latest Tue, Oct 22, 2019 (In 6 days)

BIIB Dividend

Yield --
Ex-Date --
Pay Date --
History --

BIIB Charts

52 Week Low $215.78 set on Wed, Sep 4, 2019
$215.78
1 Year
$344.00
Sep 4, 2019
Jan 23, 2019


ILMN $309.67 2.50 (0.80%)
Illumina
NASDAQ: ILMN $43 Billion Large-Cap. Nasdaq 100. S&P 500. Medical Equipment & Devices industry. 5 Year Return 88%. 1 Year Return 6%. 2019 YTD Return 5%. Earnings in 7 days on Thu, Oct 24. (Use the Earnings tab below to add this date to your calendar.)

ILMN Profile

Market Cap 43 Billion
ILMN Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (about 70% of sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (12% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 18% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.


Visit Website

ILMN Earnings

EPS 2.01 P/E Ratio 57.38
Previous Mon, Jul 29, 2019
Latest Thu, Oct 24, 2019 (In 8 days)

ILMN Dividend

Yield --
Ex-Date --
Pay Date --
History --

ILMN Charts

$263.30
1 Year
$380.76
Sep 10, 2019
Jul 10, 2019


PHG $43.24 0.02 (0.05%)
Koninklijke Philips N.V. NY Registry Shares
NYSE: PHG $42 Billion Large-Cap. Medical Diagnostics & Research industry. 5 Year Return 54%. 1 Year Return 5%. 2019 YTD Return 25%. 2.2% dividend yield. 41 total dividend payments. Paid Annually.

PHG Profile

Market Cap 42 Billion
PHG Description

Philips is a diversified global manufacturer operating in two segments: healthtech and personal health. About 60% of the company's revenue comes from the healthtech segment, which features imaging systems, ultrasound equipment, patient monitoring systems, and image-guided therapy solutions. Personal health products like domestic appliances, health and wellness, and personal care contribute the remainder of Philips' turnover. In 2017, Philips generated EUR 17.8 billion of sales and had 105,000 employees in over 100 countries.


Visit Website

PHG Earnings

EPS 0.27 P/E Ratio 25.32
Previous --
Latest --

PHG Dividend

Yield 2.22% / $0.96
Ex-Date Mon, May 13, 2019 (156 days ago)
Pay Date Thu, Jun 13, 2019
History 41 Payments (Annually)

PHG Charts

$32.98
1 Year
$48.84
Jan 3, 2019
Sep 19, 2019


HUM $275.37 1.27 (0.46%)
Humana
NYSE: HUM $37 Billion Large-Cap. S&P 500. Health Care Facilities & Services industry. 5 Year Return 115%. 1 Year Return 16%. 2019 YTD Return 2%. 0.8% dividend yield. 48 total dividend payments. Earnings in 20 days on Wed, Nov 6. (Use the Earnings tab below to add this date to your calendar.)

HUM Profile

Market Cap 37 Billion
HUM Description

Humana is one of the largest private insurance organizations participating in the Medicare Advantage program. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's TRICARE program. Additionally, the firm is a leader in stand-alone prescription drug plans offered to seniors enrolled in traditional fee-for-service Medicare. In addition, the firm has a nascent commercial offering focusing on risk arrangements alongside specialty offerings such as dental, vision, and life for smaller employers.


Visit Website

HUM Earnings

EPS 6.96 P/E Ratio 19.79
Previous Wed, Jul 31, 2019
Latest Wed, Nov 6, 2019 (In 21 days)

HUM Dividend

Yield 0.80% / $2.20
Ex-Date Fri, Sep 27, 2019 (19 days ago)
Pay Date Fri, Oct 25, 2019
History 48 Payments (Quarterly)

HUM Charts

$225.65
1 Year
$355.88
Apr 17, 2019
Nov 7, 2018


REGN $299.40 4.42 (1.45%)
Regeneron Pharmaceuticals
NASDAQ: REGN $31 Billion Large-Cap. Nasdaq 100. S&P 500. Biotech & Pharma industry. 5 Year Return 19%. 1 Year Return 25%. 2019 YTD Return 20%. Negative 5 year, 1 year & YTD returns. You may want to avoid this one until things turn around. Check out some Uptrending symbols instead. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

REGN Profile

Market Cap 31 Billion
REGN Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis and asthma; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.


Visit Website

REGN Earnings

EPS 1.77 P/E Ratio 24.20
Previous Tue, Aug 6, 2019
Latest Tue, Nov 5, 2019 (In 20 days)

REGN Dividend

Yield --
Ex-Date --
Pay Date --
History --

REGN Charts

52 Week Low $271.37 set on Fri, Sep 27, 2019
$271.37
1 Year
$442.00
Sep 27, 2019
Mar 4, 2019


IQV $144.83 1.73 (1.18%)
IQVIA Holdings
NYSE: IQV $30 Billion Large-Cap. S&P 500. Health Care Facilities & Services industry. 5 Year Return 39%. 1 Year Return 12%. 2019 YTD Return 27%. Earnings in 11 days on Mon, Oct 28. (Use the Earnings tab below to add this date to your calendar.)

IQV Profile

Market Cap 30 Billion
IQV Description

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The CRO segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The legacy IMS business provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers.


Visit Website

IQV Earnings

EPS 0.31 P/E Ratio 107.27
Previous Wed, Jul 24, 2019
Latest Mon, Oct 28, 2019 (In 12 days)

IQV Dividend

Yield --
Ex-Date --
Pay Date --
History --

IQV Charts

$104.90
1 Year
$164.13
Dec 24, 2018
Jul 1, 2019


ZBH $136.58 1.31 (0.95%)
Zimmer Biomet Holdings
NYSE: ZBH $29 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 40%. 1 Year Return 6%. 2019 YTD Return 34%. 0.7% dividend yield. 31 total dividend payments. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

ZBH Profile

Market Cap 29 Billion
ZBH Description

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 60% of total revenue is derived from sales of large joints, another 22% comes from extremities and trauma; the remaining portion is primarily related to spine and dental products.


Visit Website

ZBH Earnings

EPS 0.65 P/E Ratio 0.00
Previous Fri, Jul 26, 2019
Latest Tue, Nov 5, 2019 (In 20 days)

ZBH Dividend

Yield 0.70% / $0.96
Ex-Date Fri, Sep 27, 2019 (19 days ago)
Pay Date Thu, Oct 31, 2019
History 31 Payments (Quarterly)

ZBH Charts

All Time High $143.57 set on Fri, Sep 13, 2019.
$96.99
1 Year
$143.57
Dec 24, 2018
Sep 13, 2019


MCK $144.84 6.67 (4.83%)
McKesson
NYSE: MCK $27 Billion Large-Cap. S&P 500. Health Care Facilities & Services industry. 5 Year Return 24%. 1 Year Return 7%. 2019 YTD Return 28%. 1.1% dividend yield. 143 total dividend payments. Earnings in 13 days on Wed, Oct 30. (Use the Earnings tab below to add this date to your calendar.)

MCK Profile

Market Cap 27 Billion
MCK Description

McKesson Corporation is the largest and most complex of the leading third-party logistics providers. The company is engaged in wholesale pharmaceutical and medical products sourcing, distribution and dispensing, contract manufacturing, and related IT services to acute care hospitals and health systems, independent and chain retail pharmacies in North America, Europe, and Canada. Through acquisition and joint ventures McKesson also runs the fourth largest pharmacy chain and provides technology and consulting services to manufacturers, pharmacies, physician offices, surgery centers, long-term care facilities, and home healthcare businesses.


Visit Website

MCK Earnings

EPS 2.25 P/E Ratio 0.00
Previous Wed, Jul 31, 2019
Latest Wed, Oct 30, 2019 (In 14 days)

MCK Dividend

Yield 1.13% / $1.64
Ex-Date Fri, Aug 30, 2019 (47 days ago)
Pay Date Tue, Oct 1, 2019
History 143 Payments (Quarterly)

MCK Charts

$106.11
1 Year
$150.82
Dec 24, 2018
Aug 23, 2019


ALXN $99.51 5.30 (5.06%)
Alexion Pharmaceuticals
NASDAQ: ALXN $25 Billion Large-Cap. Nasdaq 100. S&P 500. Biotech & Pharma industry. 5 Year Return 40%. 1 Year Return 23%. 2019 YTD Return 1%. Earnings in 6 days on Wed, Oct 23. (Use the Earnings tab below to add this date to your calendar.)

ALXN Profile

Market Cap 25 Billion
ALXN Description

Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and generalized myasthenia gravis. Next-generation Ultomiris was recently approved in paroxysmal nocturnal hemoglobinuria. Strensiq and Kanuma target other ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need and complement-mediated disorders.


Visit Website

ALXN Earnings

EPS 2.05 P/E Ratio 392.83
Previous Wed, Jul 24, 2019
Latest Wed, Oct 23, 2019 (In 7 days)

ALXN Dividend

Yield --
Ex-Date --
Pay Date --
History --

ALXN Charts

52 Week Low $92.56 set on Mon, Dec 24, 2018
$92.56
1 Year
$141.86
Dec 24, 2018
Apr 10, 2019


A $75.27 0.48 (0.63%)
Agilent Technologies
NYSE: A $24 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 101%. 1 Year Return 12%. 2019 YTD Return 15%. 0.9% dividend yield. 31 total dividend payments.

A Profile

Market Cap 24 Billion
A Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (46% of fiscal 2018 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (19%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse with operations in the U.S. (29%) and China (21%) representing the largest country concentrations.


Visit Website

A Earnings

EPS 0.61 P/E Ratio 21.41
Previous Wed, Aug 14, 2019
Latest Mon, Nov 18, 2019 (In 33 days)

A Dividend

Yield 0.87% / $0.66
Ex-Date Mon, Sep 30, 2019 (16 days ago)
Pay Date Wed, Oct 23, 2019
History 31 Payments (Quarterly)

A Charts

$61.01
1 Year
$82.27
Oct 24, 2018
Mar 21, 2019


IDXX $279.57 2.69 (0.95%)
IDEXX Laboratories
NASDAQ: IDXX $23 Billion Large-Cap. Nasdaq 100. S&P 500. Medical Equipment & Devices industry. 5 Year Return 368%. 1 Year Return 22%. 2019 YTD Return 53%. Earnings in 14 days on Thu, Oct 31. (Use the Earnings tab below to add this date to your calendar.)

IDXX Profile

Market Cap 23 Billion
IDXX Description

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. Idexx gets about 39% of its revenue from outside the United States.


Visit Website

IDXX Earnings

EPS 1.46 P/E Ratio 51.29
Previous Thu, Aug 1, 2019
Latest Thu, Oct 31, 2019 (In 15 days)

IDXX Dividend

Yield --
Ex-Date --
Pay Date --
History --

IDXX Charts

All Time High $292.17 set on Fri, Jul 19, 2019.
$176.11
1 Year
$292.17
Jan 3, 2019
Jul 19, 2019


FMS $33.87 0.19 (0.56%)
Fresenius Medical Care AG
NYSE: FMS $21 Billion Large-Cap. Health Care Providers industry. 5 Year Return 1%. 1 Year Return 18%. 2019 YTD Return 4%. 1.9% dividend yield. 22 total dividend payments. Paid Annually. Earnings in 12 days on Tue, Oct 29. (Use the Earnings tab below to add this date to your calendar.)

FMS Profile

Market Cap 21 Billion
FMS Description

Fresenius Medical Care is the largest dialysis company in the world, treating over 323,000 patients in 3,900 clinics across the globe. In addition to providing dialysis services, the firm is also a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius supplies roughly one third of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 70% of firmwide revenue, products approximately 20%, with the remaining 10% driven by the company's care coordination and ancillary operations.


Visit Website

FMS Earnings

EPS 0.42 P/E Ratio 10.69
Previous Tue, Jul 30, 2019
Latest Tue, Oct 29, 2019 (In 13 days)

FMS Dividend

Yield 1.93% / $0.66
Ex-Date Fri, May 17, 2019 (152 days ago)
Pay Date Fri, May 31, 2019
History 22 Payments (Annually)

FMS Charts

52 Week Low $30.99 set on Thu, Jan 3, 2019
$30.99
1 Year
$49.93
Jan 3, 2019
Oct 16, 2018


SNN $47.46 0.46 (0.98%)
Smith & Nephew SNATS
NYSE: SNN $20 Billion Large-Cap. Medical Equipment & Devices industry. 5 Year Return 56%. 1 Year Return 40%. 2019 YTD Return 30%. This is Uptrending. A good sign. 1.9% dividend yield. 40 total dividend payments. Paid Biannually. Since Earnings 24%.

SNN Profile

Market Cap 20 Billion
SNN Description

Smith & Nephew designs, manufactures, and markets orthopedic devices and wound-care solutions. Approximately three fourths of the U.K.-based firm's revenue comes from knee replacements, hip implants, nails, fixation devices, and arthroscopy tools. The remaining 25% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from developed European and Asian markets, 40% is from the United States, and emerging markets account for the remainder.


Visit Website

SNN Earnings

EPS 0.00 P/E Ratio 25.44
Previous --
Latest Thu, Feb 7, 2019 (251 days ago) Price +23.79%

SNN Dividend

Yield 1.85% / $0.88
Ex-Date Thu, Apr 4, 2019 (195 days ago)
Pay Date Wed, May 8, 2019
History 40 Payments (Biannual)

SNN Charts

All Time High $48.93 set on Thu, Sep 26, 2019.
$32.22
1 Year
$48.93
Oct 29, 2018
Sep 26, 2019


CNC $45.54 0.33 (0.73%)
Centene
NYSE: CNC $19 Billion Large-Cap. S&P 500. Health Care Facilities & Services industry. 5 Year Return 131%. 1 Year Return 37%. 2019 YTD Return 19%. Earnings in 5 days on Tue, Oct 22. (Use the Earnings tab below to add this date to your calendar.)

CNC Profile

Market Cap 19 Billion
CNC Description

Centene Corp offers healthcare plans to the United States government-sponsored healthcare programs, with a focus on uninsured individuals. It helps members access care, coordinates referrals to health and social services, and provides education and outreach programs to help its members select healthcare services. Centene's managed care segment provides health plan coverage to individuals through government subsidized programs, including Medicare and Medicaid. The specialty services segment consists of specialty companies offering healthcare services and products to state programs, correctional facilities, healthcare organizations, and other commercial organizations. The managed care segment contributes to the vast majority of the firm's overall revenue.


Visit Website

CNC Earnings

EPS 1.20 P/E Ratio 28.45
Previous Tue, Jul 23, 2019
Latest Tue, Oct 22, 2019 (In 6 days)

CNC Dividend

Yield --
Ex-Date --
Pay Date --
History --

CNC Charts

52 Week Low $41.62 set on Tue, Oct 1, 2019
$41.62
1 Year
$74.49
Oct 1, 2019
Dec 4, 2018


RMD $131.16 0.71 (0.54%)
ResMed
NYSE: RMD $19 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 180%. 1 Year Return 23%. 2019 YTD Return 17%. 1.2% dividend yield. 29 total dividend payments. Earnings in 7 days on Thu, Oct 24. (Use the Earnings tab below to add this date to your calendar.)

RMD Profile

Market Cap 19 Billion
RMD Description

ResMed Inc is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns 65% of revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payor in the out-of-hospital setting.


Visit Website

RMD Earnings

EPS 0.48 P/E Ratio 31.80
Previous Thu, Jul 25, 2019
Latest Thu, Oct 24, 2019 (In 8 days)

RMD Dividend

Yield 1.19% / $1.56
Ex-Date Wed, Aug 14, 2019 (63 days ago)
Pay Date Thu, Sep 19, 2019
History 29 Payments (Quarterly)

RMD Charts

All Time High $141.25 set on Fri, Sep 6, 2019.
$90.64
1 Year
$141.25
Jan 29, 2019
Sep 6, 2019


ABC $86.05 2.85 (3.43%)
AmerisourceBergen
NYSE: ABC $18 Billion Large-Cap. S&P 500. Health Care Facilities & Services industry. 5 Year Return 13%. 1 Year Return 8%. 2019 YTD Return 16%. 1.9% dividend yield. 72 total dividend payments. Earnings in 21 days on Thu, Nov 7. (Use the Earnings tab below to add this date to your calendar.)

ABC Profile

Market Cap 18 Billion
ABC Description

AmerisourceBergen is a leading global third-party logistics provider engaged in wholesale pharmaceutical sourcing and distribution of specialty, brand-name, and generic pharmaceuticals and related services to acute-care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, dialysis clinics, and other healthcare customers. By acquiring smaller companies, management has attained the ability to compound sterile preparations, distribute veterinary pharmaceuticals and vaccines, transport biopharmaceuticals, and provide inventory and reimbursement consulting services to providers.


Visit Website

ABC Earnings

EPS 1.44 P/E Ratio 13.91
Previous Thu, Aug 1, 2019
Latest Thu, Nov 7, 2019 (In 22 days)

ABC Dividend

Yield 1.86% / $1.60
Ex-Date Fri, Aug 16, 2019 (61 days ago)
Pay Date Tue, Sep 3, 2019
History 72 Payments (Quarterly)

ABC Charts

$69.36
1 Year
$94.85
Dec 26, 2018
Oct 19, 2018


MTD $668.50 11.50 (1.69%)
Mettler-Toledo
NYSE: MTD $18 Billion Large-Cap. S&P 500. Medical Equipment & Devices industry. 5 Year Return 177%. 1 Year Return 16%. 2019 YTD Return 22%. Earnings in 21 days on Thu, Nov 7. (Use the Earnings tab below to add this date to your calendar.)

MTD Profile

Market Cap 18 Billion
MTD Description

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (50% of sales), industrial (42%), and food retail industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances.


Visit Website

MTD Earnings

EPS 5.15 P/E Ratio 38.09
Previous Thu, Aug 1, 2019
Latest Thu, Nov 7, 2019 (In 22 days)

MTD Dividend

Yield --
Ex-Date --
Pay Date --
History --

MTD Charts

$500.74
1 Year
$873.51
Jan 3, 2019
Jul 3, 2019


LH $169.98 2.20 (1.31%)
Laboratory
NYSE: LH $17 Billion Large-Cap. S&P 500. Health Care Facilities & Services industry. 5 Year Return 72%. 1 Year Return 2%. 2019 YTD Return 34%. Earnings in 7 days on Thu, Oct 24. (Use the Earnings tab below to add this date to your calendar.)